pyrazines has been researched along with tubacin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, KC; Bradner, JE; Chauhan, D; Hideshima, T; Richardson, P; Schreiber, SL; Wong, J | 1 |
| Puthalakath, H; Strasser, A | 1 |
| Bradner, JE; Cohen, JI; Kawada, J; Mazitschek, R; Zou, P | 1 |
| Che, XF; Kohno, N; Komatsu, S; Miyazawa, K; Moriya, S; Yokoyama, T | 1 |
| Cebotaru, L; Cebotaru, V; Guggino, WB; Rapino, D | 1 |
| Fischer, U; Hoffmann, MJ; Jung, M; Niegisch, G; Rosik, L; Schulz, WA | 1 |
6 other study(ies) available for pyrazines and tubacin
| Article | Year |
|---|---|
Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma.
Topics: Anilides; Boronic Acids; Bortezomib; Cell Line, Tumor; Dose-Response Relationship, Drug; Flow Cytometry; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Immunoblotting; Inhibitory Concentration 50; Multiple Myeloma; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Proteins; Pyrazines; RNA, Small Interfering; Tubulin | 2005 |
Fold up or perish: unfolded protein response and chemotherapy.
Topics: Anilides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Endoplasmic Reticulum; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Neoplasms; Protease Inhibitors; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Folding; Pyrazines | 2008 |
Tubacin kills Epstein-Barr virus (EBV)-Burkitt lymphoma cells by inducing reactive oxygen species and EBV lymphoblastoid cells by inducing apoptosis.
Topics: Anilides; Apoptosis; B-Lymphocytes; Boronic Acids; Bortezomib; Burkitt Lymphoma; Caspase 3; Cell Line, Tumor; Cell Transformation, Viral; Drug Synergism; Enzyme Inhibitors; Genes, Viral; Herpesvirus 4, Human; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Protease Inhibitors; Pyrazines; Reactive Oxygen Species | 2009 |
Combined treatment with SAHA, bortezomib, and clarithromycin for concomitant targeting of aggresome formation and intracellular proteolytic pathways enhances ER stress-mediated cell death in breast cancer cells.
Topics: Anilides; Animals; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Breast Neoplasms; Cell Death; Cell Line, Tumor; Cell Proliferation; Clarithromycin; Drug Screening Assays, Antitumor; Endoplasmic Reticulum Stress; Female; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Inclusion Bodies; Intracellular Space; Mice; Proteolysis; Pyrazines; Transcription Factor CHOP; Vorinostat | 2013 |
Correcting the cystic fibrosis disease mutant, A455E CFTR.
Topics: Anilides; Animals; Boronic Acids; Bortezomib; Chlorocebus aethiops; COS Cells; Cycloheximide; Cystic Fibrosis Transmembrane Conductance Regulator; Gene Expression; Genetic Complementation Test; Half-Life; Humans; Hydroxamic Acids; Leupeptins; Mutation; Plasmids; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Proteolysis; Pyrazines; Small Molecule Libraries; Transfection | 2014 |
Limited efficacy of specific HDAC6 inhibition in urothelial cancer cells.
Topics: Acetylation; Aged; Aged, 80 and over; Anilides; Antineoplastic Agents; Benzoquinones; Boronic Acids; Bortezomib; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Gene Expression; Histone Deacetylase 6; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Indoles; Inhibitory Concentration 50; Lactams, Macrocyclic; Middle Aged; Protein Processing, Post-Translational; Pyrazines; Urinary Bladder Neoplasms; Urothelium | 2014 |